Treatment of intravenous thrombolysis with half dose recombinant human prourokinase reducing the rate of tirofiban use during early routine catheterization period.
Asian journal of surgery（2022）
关键词
Catheterization,No-reflow,Percutaneous coronary intervention,Recombinant human prourokinase,Slow flow,Tirofiban
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要